Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..
Hospitalized patients with coronavirus disease 2019 (COVID-19) experiencing respiratory symptoms have different complications (inflammatory, co-infection, and thrombotic) that are identifiable by analytics patterns. Personalized treatment decisions decreased early mortality (odds ratio [OR] .144; 95% confidence interval [CI] .03-.686; P = .015). Increasing age (OR 1.06; P = .038) and therapeutic effort limitation (OR 9.684; P < .001) were associated with higher mortality.
Errataetall: |
CommentIn: Clin Infect Dis. 2022 Jan 7;74(1):149-151. - PMID 32667978 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
---|---|
Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 74(2022), 1 vom: 07. Jan., Seite 127-132 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Garcia-Vidal, Carolina [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 14.01.2022 Date Revised 14.01.2022 published: Print CommentIn: Clin Infect Dis. 2022 Jan 7;74(1):149-151. - PMID 32667978 Citation Status MEDLINE |
---|
doi: |
10.1093/cid/ciaa964 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM312264992 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM312264992 | ||
003 | DE-627 | ||
005 | 20231225144034.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/cid/ciaa964 |2 doi | |
028 | 5 | 2 | |a pubmed24n1040.xml |
035 | |a (DE-627)NLM312264992 | ||
035 | |a (NLM)32649747 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Garcia-Vidal, Carolina |e verfasserin |4 aut | |
245 | 1 | 0 | |a Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019 |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.01.2022 | ||
500 | |a Date Revised 14.01.2022 | ||
500 | |a published: Print | ||
500 | |a CommentIn: Clin Infect Dis. 2022 Jan 7;74(1):149-151. - PMID 32667978 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com. | ||
520 | |a Hospitalized patients with coronavirus disease 2019 (COVID-19) experiencing respiratory symptoms have different complications (inflammatory, co-infection, and thrombotic) that are identifiable by analytics patterns. Personalized treatment decisions decreased early mortality (odds ratio [OR] .144; 95% confidence interval [CI] .03-.686; P = .015). Increasing age (OR 1.06; P = .038) and therapeutic effort limitation (OR 9.684; P < .001) were associated with higher mortality | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a patterns | |
650 | 4 | |a personalized therapy | |
650 | 4 | |a pneumonia | |
700 | 1 | |a Moreno-García, Estela |e verfasserin |4 aut | |
700 | 1 | |a Hernández-Meneses, Marta |e verfasserin |4 aut | |
700 | 1 | |a Puerta-Alcalde, Pedro |e verfasserin |4 aut | |
700 | 1 | |a Chumbita, Mariana |e verfasserin |4 aut | |
700 | 1 | |a Garcia-Pouton, Nicole |e verfasserin |4 aut | |
700 | 1 | |a Linares, Laura |e verfasserin |4 aut | |
700 | 1 | |a Rico, Verónica |e verfasserin |4 aut | |
700 | 1 | |a Cardozo, Celia |e verfasserin |4 aut | |
700 | 1 | |a Martínez, José Antonio |e verfasserin |4 aut | |
700 | 1 | |a García, Felipe |e verfasserin |4 aut | |
700 | 1 | |a Mensa, Josep |e verfasserin |4 aut | |
700 | 1 | |a Castro, Pedro |e verfasserin |4 aut | |
700 | 1 | |a Nicolás, José María |e verfasserin |4 aut | |
700 | 1 | |a Muñoz, José |e verfasserin |4 aut | |
700 | 1 | |a Vidal, David |e verfasserin |4 aut | |
700 | 1 | |a Soriano, Alex |e verfasserin |4 aut | |
700 | 0 | |a COVID19-Researchers |e verfasserin |4 aut | |
700 | 1 | |a Bodro, Marta |e investigator |4 oth | |
700 | 1 | |a Morata, Laura |e investigator |4 oth | |
700 | 1 | |a Ambrosioni, Juan |e investigator |4 oth | |
700 | 1 | |a Agüero, Daiana |e investigator |4 oth | |
700 | 1 | |a Torres, Berta |e investigator |4 oth | |
700 | 1 | |a González, Ana |e investigator |4 oth | |
700 | 1 | |a De la Mora, Lorena |e investigator |4 oth | |
700 | 1 | |a Linares, Laura |e investigator |4 oth | |
700 | 1 | |a Meira, Fernanda |e investigator |4 oth | |
700 | 1 | |a Macaya, Irene |e investigator |4 oth | |
700 | 1 | |a Rodriguez, Natalia |e investigator |4 oth | |
700 | 1 | |a Nicolas, David |e investigator |4 oth | |
700 | 1 | |a Albiach, Laia |e investigator |4 oth | |
700 | 1 | |a Almuedo, Alex |e investigator |4 oth | |
700 | 1 | |a Angeles Marcos, Maria |e investigator |4 oth | |
700 | 1 | |a Angeles Marcos, Maria |e investigator |4 oth | |
700 | 1 | |a Fernandez-Pittol, Mariana |e investigator |4 oth | |
700 | 1 | |a Fidalgo, Berta |e investigator |4 oth | |
700 | 1 | |a Camprubí, Daniel |e investigator |4 oth | |
700 | 1 | |a Cilloniz, Catia |e investigator |4 oth | |
700 | 1 | |a Torres, Antoni |e investigator |4 oth | |
700 | 1 | |a Tellez, Adrian |e investigator |4 oth | |
700 | 1 | |a Fernández, Sara |e investigator |4 oth | |
700 | 1 | |a Sanjuan, Gemma |e investigator |4 oth | |
700 | 1 | |a Cano, Pau |e investigator |4 oth | |
700 | 1 | |a Caellas, David |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 74(2022), 1 vom: 07. Jan., Seite 127-132 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
773 | 1 | 8 | |g volume:74 |g year:2022 |g number:1 |g day:07 |g month:01 |g pages:127-132 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciaa964 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 74 |j 2022 |e 1 |b 07 |c 01 |h 127-132 |